Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 34 results for "roche"

Cipla teams up with Roche Pharma to sell cancer therapy drugs in India
Business Standard

Cipla teams up with Roche Pharma to sell cancer therapy drugs ...

Drug firm Cipla and Roche Pharma India has said that they have entered an agreement under which Cipla will promote and distribute tocilizumab and Syndyma, the 2nd brand of Roche's cancer therapy bevacizumab in India.This partnership is in line with Cipla and ... Business Standard, 1 month ago
Cipla gains 1% on partnership with Roche Pharma Money Control, 1 month ago

12 images for roche

Mizoram Express, 1 month ago
Mizoram Express, 1 month ago
Mizoram Express, 1 month ago
Business Standard, 1 month ago
Mizoram Express, 1 month ago
Mizoram Express, 1 month ago
The Telegraph UK, 1 month ago
Money Control, 1 month ago
Business Standard, 2 months ago
Business Standard, 4 months ago

Roche launches new lung, bladder cancer drug in India

Tecentriq has shown to extend survival and improve the quality of life in the approved indications, Roche said in a statement. The product has been approved in India "for two types of cancers: non-small cell lung cancer (NSCLC) and Urothelial Carcinoma, a ...
 Money Control3 weeks ago

Ex-Roche scientist Reed to head Sanofi R&D as Zerhouni retires

(Reuters) - Sanofi said on Tuesday it had hired former Roche top scientist John Reed to head its research operations from July 1, when Elias Zerhouni retires from the French drugmaker.
 Reuters2 days ago Roche names Pao head of drugs research and early development  Reuters1 month ago

FDA declines to approve Pfizer's biosimilar to Roche's cancer drug

(Reuters) - Pfizer Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve the company's biosimilar to Roche's breast cancer drug, Herceptin, and sought additional technical information.
 Reuters3 days ago FDA declines to approve Pfizer biosimilar of Roche's cancer drug  Reuters3 days ago

Roche's Hemlibra gets speedy FDA review for wider use

ZURICH (Reuters) - Roche's hemophilia A drug Hemlibra will get an accelerated review by U.S. regulators for use in a new group of patients, a key part of the Swiss drug company's plans to muscle in on turf dominated by rivals including Shire.
 Reuters1 week ago Roche shares drop after deaths of patients taking Hemlibra  Reuters4 weeks ago Roche CEO says new drugs will offset biosimilar incursions  Reuters1 month ago Roche says hemophilia drug Hemlibra wins EU approval  Reuters1 month ago

Tokyo court rejects Shire claim against Roche hemophilia drug

ZURICH (Reuters) - A Tokyo court has ruled that Shire's claim against Swiss drugmaker Roche's new Hemlibra hemophilia medicine should be dismissed, Roche's Japanese subsidiary Chugai said on Wednesday, helping to clear up legal uncertainty over the ...
 Reuters4 weeks ago Roche says Japanese court dismisses Shire claim against Hemlibra  Reuters4 weeks ago

Roche's Tecentriq cocktail adds to lung cancer survival success

ZURICH (Reuters) - Roche's Tecentriq immunotherapy combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss company said as it seeks an edge on Merck and Bristol-Myers Squibb.
 Reuters1 month ago Roche's Tecentriq cocktail notches another lung cancer success  Reuters1 month ago

Britain's use of copycat biotech drugs takes off while U.S. lags

LONDON (Reuters) - Cut-price copies of an expensive Roche biotech drug for blood cancer have taken 80 percent of the British market since launching last year, saving the healthcare system 80 million pounds ($113 million) a year, experts said on Wednesday.
 Reuters1 month ago Drug copies ready to take next bite out of Roche's cancer sales  Reuters2 months ago

Roche's Tecentriq notches third cancer cocktail trial win

ZURICH (Reuters) - Roche's immunotherapy Tecentriq on Tuesday racked up a third trial win in combination with other cancer drugs, a boost for the Swiss drugmaker as it seeks to muscle in on space dominated by Merck and Bristol-Myers Squibb.
 Reuters1 month ago Roche notches fresh win amid crowd of immunotherapy cocktails  Reuters2 months ago

Roche to buy Flatiron Health for $1.9 billion to expand cancer care portfolio

(Reuters) - Swiss drugmaker Roche Holding AG said on Thursday it would buy the rest of U.S. cancer data company Flatiron Health for $1.9 billion to speed development of cancer medicines and support its efforts to price them based on how well they work.
 Reuters2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less